Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Retatrutide

Pre-approval Expanded Access of Retatrutide (LY3437943)

Eli Lilly · Phase n/r · Available · Enrollment n/r

NCT07629401

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Registry arm not namedn/rn/rn/rn/r

Not shown

  • Registry arm not named: endpoint not reported